A Possible Biomarker for COVID-19 Cognitive Impairment

The study covered in this summary was published on as a preprint and has not yet been peer reviewed. Key Takeaways This study demonstrated that participants with previous SARS-CoV-2 infections had mild to moderate cognitive impairment up to 4 months after diagnosis, independently of baseline cognitive function. Mild cognitive decline is […]

Read More

COVID-19 insights: Waning immunity will impact long-range forecasts

The latest takeaways from IHME: Regional updates: China continues the zero-COVID strategy and reports no increase in cases. South Africa may be reaching a peak of the BA.4/BA.5 winter surge. The United States is experiencing an increase in Omicron cases – likely due to behavioral changes, and possibly due to […]

Read More

Does COVID-19 Raise the Risk for Diabetes?

This transcript has been edited for clarity. Does having had a COVID-19 infection increase your risk for the development of diabetes subsequently? Some data say yes and other data say no. No matter what, it’s obviously important to screen people for diabetes routinely, pandemic or not. Remember, screening should start […]

Read More
Translate »